Followers | 218 |
Posts | 38765 |
Boards Moderated | 0 |
Alias Born | 04/29/2008 |
Saturday, March 07, 2009 1:47:57 PM
Even at 14 cents, DKAM is valued at over $15 million (fully diluted), or 2.5 to 7 times annual sales. That doesn't sound unreasonably high to me at all, especially when you consider they just paid Olifant 70% of their annual sales over a 4 year period. Personally, I think that one or more stockholders who bought on expectations that the stock would have taken off by now are giving up and putting their shares up for sale at whatever they can get. There are not a lot of buyers these days for any stock, let alone one with the risks of DKAM, so the price is kind of stuck. I would not be surprised if some smaller stockholders and potential investors are waiting to see the results of the last Q, with Israel, Germany and some Leyrat and Olifant. If it's strong, I would expect a modest increase in the PPS. If it's around last Q, or worse, I would look for a further decline. If sales increase somewhat, margins go back to historical levels and net loss is around $1 million for the quarter (my personal guess), I think it will sit in this range for some time.
All MHO.
“Any fool can criticize, condemn and complain and most fools do.”
Benjamin Franklin
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM